When could we see Johnson & Johnson's single-dose vaccine?

[KARE 11 News, January 05, 2021] Johnson & Johnson's investigational COVID-19 vaccine has been called a potential "game-changer." If all goes well, J&J hopes to seek emergency use authorization for its single-dose vaccine in February. Allina Health is running the only clinical trial site in Minnesota part of the study called "ENSEMBLE."

The Phase 3 trial initially had a goal of enrolling 60,000 participants worldwide.

"They were obviously getting a lot more COVID cases than they were projecting initially so they didn't think they needed to enroll 60,000; they only needed to enroll 40,000," explained Dr. Frank Rhame, an Allina Health infectious disease physician and site principal investigator of the trial.

Posted on January 05, 2021 in coronavirus, Infectious Disease